Male health and ED clinic marketing rules

Men’s health clinics that treat erectile dysfunction work in one of the hardest corners of healthcare marketing. The topic is personal, many patients put off care because they are embarrassed, the ad platforms treat it as a sensitive category, and the market is full of products that promise far more than they can show. A clinic that markets plainly and protects privacy stands out for the right reasons.

This guide covers what is specific to ED and male sexual health: describing the evaluation, what FDA device status really means for your claims, products sold outside the clinic, testimonials, Google’s sexual health ad rules and discreet patient contact. If your clinic also offers testosterone therapy, read our guide to testosterone clinic marketing as well, since it covers drug labeling, Schedule III and telehealth prescribing, which we do not repeat here. Shock wave device types and ED claims are covered in more depth in our guide to shockwave therapy marketing. For permanence and no-scalpel claims, see vasectomy clinic marketing.

This is general information, not legal or medical advice. Sources cited were checked on October 29, 2026: the FDA device classification and De Novo databases, 21 CFR 807.97, 876.5020 and 876.5021, the FDA page on tainted sexual enhancement products (content current as of October 15, 2026), NIDDK pages on erectile dysfunction (last reviewed October 2024), the FTC Health Products Compliance Guidance, 16 CFR 255.2, 45 CFR 164.508 and 164.522, and Google Ads policy pages. State rules on advertising, telehealth and privacy differ by state. Check your plans with a health care attorney.

Lead with the evaluation, not the fix

NIDDK, part of the National Institutes of Health, describes ED as a condition that prevents a man from getting or keeping an erection firm enough for sex, and says ED may be a symptom of another health problem. It lists diseases and conditions that affect blood vessels, nerves or hormones, certain medicines, mental or emotional issues and lifestyle factors among the possible causes.

That gives a men’s health clinic an honest and useful message: the first step is finding out why. Pages built around the evaluation tend to be easier to defend than pages built around a single treatment, and they speak to the patient who is unsure what is wrong.

A first visit page that explains what the provider asks about, what an exam includes and what testing your providers may order.
A treatment options page that describes the categories of care your clinicians offer in neutral words, and says the provider recommends a plan after evaluation.
A referral note that says when you send patients to their primary care doctor, a urologist or another specialist, if that is your practice.
A cost page with visit prices and what is and is not included.

Keep the language clinical and calm. Plain terms like erectile dysfunction, evaluation and treatment options read as more trustworthy than slang, and they keep your pages and ads clear of the sexual content problems described below.

Device claims: cleared, approved and what the database shows

Many ED clinics market devices or device-based procedures. The FDA status of each one decides what you can say about it, and the details matter.

External penile rigidity devices. Under 21 CFR 876.5020, these include vacuum pumps, constriction rings and penile splints. They are Class II with special controls and are exempt from premarket notification, subject to the limits in 876.9.
Non-medicated topical formulations. 21 CFR 876.5021 sets out a Class II device type for a non-medicated topical product applied to the penis that works by inducing a temperature change. The FDA De Novo database shows the request that created this classification was decided on June 9, 2023.
Shock wave devices. When we searched the FDA device classification database on October 29, 2026, we found shock wave device types for kidney stones, gallbladder stones, intravascular lithotripsy, diabetic foot ulcers, pain relief and nonunion fractures, and no classification that names erectile dysfunction.

Before you write a single line about a device, ask the manufacturer for the FDA submission number and the cleared or approved indications, then look it up yourself in the FDA databases listed in our sources. If the indications do not include erectile dysfunction, your pages should not say or imply that the device is FDA cleared or approved for ED.

Wording matters even when a device is cleared. Under 21 CFR 807.97, a 510(k) clearance does not in any way denote official approval of the device, and any representation that creates an impression of official approval because of the premarket notification is misleading and misbranding. Say “FDA cleared for” and the exact indication only when that is true, and never shorten it to “FDA approved”.

Products sold outside your clinic

Patients often arrive having tried supplements or pills bought online. The FDA warns that many products that claim to help with sexual enhancement or treat sexual dysfunction, including male enhancement supplements and pills sold for ED, are likely to be contaminated with dangerous hidden ingredients. It says these products are sometimes falsely advertised as dietary supplements, food or all-natural treatments, and that its list of notifications covers only a small fraction of the contaminated products on the market.

That has two marketing consequences. First, think hard before selling or promoting any over-the-counter sexual health product from your site; your clinic’s name is then attached to that product’s claims. Second, you can write useful patient education that points readers to the FDA page and encourages them to tell their provider about anything they take, without naming or attacking a specific product.

Claims and testimonials

The FTC Health Products Compliance Guidance says health claims need competent and reliable scientific evidence, generally randomized, controlled human clinical testing, and that the FTC looks at the net impression of an ad, including claims implied by images and context. In ED marketing, implied claims often come from suggestive photos, couples imagery and taglines about confidence or performance.

Do not promise results: restored function, lasting effects, a permanent fix or an end to medication.
Do not state or imply success rates, response rates or how long results last unless a qualified reviewer has confirmed you have evidence for that exact claim.
Do not describe any treatment as painless, risk free or side effect free.
Keep imagery neutral. Your office, your clinicians and plain graphics work; suggestive photos invite both implied claims and ad disapprovals.

Testimonials need extra care here. Under 16 CFR 255.2(b), an endorsement about a key attribute of a product or service will likely be read as representing what people will generally achieve, so if you cannot show that a story is representative, you need to clearly disclose what patients can generally expect. A testimonial also discloses that a person was your patient for ED, so you need a signed HIPAA authorization under 45 CFR 164.508(a)(3) before using it. Our guide to patient testimonials and before and after photos covers the details.

Google Ads: sexual health and sensitive categories

Google has a specific Sexual health and wellness policy. It allows promotion of personal lubricants and prescription drugs for erectile dysfunction and female sexual interest or arousal disorder on the Google Display Network and YouTube in limited cases, and only when all of its conditions are met:

Ads are not promoted in a way that focuses on sexual pleasure or enhancement.
Ads do not use sexually suggestive elements and themes.
Ads target only users 18 or older.
Ads respect the serving and location restrictions of the Healthcare and medicines policy, and businesses such as providers of prescription drug services must apply and be approved to advertise.
Ads comply with local laws in the regions the campaigns target.

Google lists the United States among the locations where prescription drugs for erectile dysfunction may be promoted by pharmaceutical manufacturers, online pharmacies and telemedicine providers that have applied first. Ads that break these conditions fall under the Sexual content, Inappropriate content and Healthcare and medicines policies. The Sexual content policy restricts ads and destinations with sexual content and says ads must not target minors.

Targeting is limited too. Google’s personalized advertising policy lists Health and Sexual content among its sensitive interest categories and says advertisers promoting products and services in those categories cannot use advertiser-curated audiences, such as remarketing lists. Plan search campaigns around clear, clinical keywords and landing pages that match them. Our Google Ads for practices page explains how we set up campaigns in restricted healthcare categories, and the healthcare ad policy basics guide covers the platform rules more broadly.

Discreet contact and privacy

Many ED patients care a great deal about who sees their mail, texts and calendar. HIPAA supports that. Under 45 CFR 164.522(b), a covered health care provider must permit patients to request, and must accommodate reasonable requests, to receive communications by alternative means or at alternative locations. The provider may ask for the request in writing, but may not require the patient to explain why. Self-pay requests to keep a visit from a health plan, and teen patients, are covered in our guide to sexual health and STI clinic marketing.

Ask each new patient how they want to be contacted: which phone, which email, and whether voicemail and texts are acceptable.
Write reminder texts and emails so they do not name the condition or treatment.
Use a neutral sender name and return address if patients ask for one.
Keep advertising pixels off intake forms, booking pages and condition pages, so a visit to your ED page is not sent to ad platforms. See our guide to tracking pixels on practice websites.

Marketing messages to existing patients are a separate question. Using patient information to send marketing generally requires an authorization under 45 CFR 164.508(a)(3), with limited exceptions. Our guide to HIPAA marketing rules explains where the line falls, and the guide to text message appointment reminders covers reminder texts.

Illustration: rewriting a landing page

Illustration. A men’s health clinic has a landing page with a couple in bed, the headline “Get your confidence back in one visit” and a badge that says a shock wave device is FDA approved. The clinic reviews it against the points above.

Imagery. The couple photo is replaced with a photo of the clinic’s consultation room.
Headline. The headline becomes “Erectile dysfunction evaluation and treatment options”, which describes the service without promising a result.
Device badge. The clinic asks the manufacturer for the submission number, looks it up and finds no indication for erectile dysfunction. The badge comes off.
Form. The booking form asks for name, preferred contact method and preferred times, with no symptom fields, and the ad platform pixel is removed from the page.

The page now explains what the first visit includes, who the providers are and what it costs. It promises nothing it cannot support.

Common mistakes

Calling a cleared device “FDA approved”, or implying clearance for ED when the indications do not include it.
Using suggestive imagery or wording that triggers Google’s sexual content rules and implies results.
Advertising success rates or lasting results without evidence a qualified reviewer has checked.
Selling over-the-counter enhancement products the clinic cannot vouch for.
Sending reminders that name the condition to a shared phone or email.
Using a patient’s story without a signed HIPAA authorization.

Men’s health clinics that offer prostate cancer screening should follow the federal shared decision approach, which asks men aged 55 to 69 to decide about the PSA test with a clinician. Our guide to prostate cancer screening outreach covers screening pages, PSA claims, coverage and free PSA events.

How we help

We build and run websites, local search, ads and phone handling for independent practices and clinics. For a men’s health clinic, that means evaluation and treatment pages written in plain clinical language, booking forms that do not collect symptoms, ad campaigns set up for restricted healthcare categories, and tracking kept off sensitive pages. Our work is built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool; if it is not covered, we do not route patient information through it. We do not write outcome claims, and we do not promise patients, leads or rankings. See our Google Ads for practices page, or the healthcare marketing rules guide for related topics.

Can we say our shock wave treatment for ED is FDA approved?

Only if it is true for that indication, which you should verify yourself. When we searched the FDA device classification database on October 29, 2026, we found no shock wave classification naming erectile dysfunction. Ask the manufacturer for the submission number and indications, and remember that under 21 CFR 807.97 a 510(k) clearance is not an approval.

Can we run Google ads for an ED clinic?

Often yes, within limits. Google’s Sexual health and wellness policy requires ads that do not focus on sexual pleasure or enhancement, no sexually suggestive elements, targeting only users 18 or older, and compliance with the Healthcare and medicines policy, including applying first for prescription drug services.

Can we use remarketing for ED patients?

Google’s personalized advertising policy says advertisers promoting products and services in sensitive interest categories, which include Health and Sexual content, cannot use advertiser-curated audiences such as remarketing lists.

Can we share a patient’s success story?

Only with a signed HIPAA authorization under 45 CFR 164.508(a)(3), and with care under 16 CFR 255.2(b): if the story is not representative, you must clearly disclose what patients can generally expect.

A patient asked us not to call their home number. Do we have to agree?

Under 45 CFR 164.522(b), a covered health care provider must accommodate reasonable requests to receive communications by alternative means or at alternative locations, and may not require the patient to explain why. You may ask for the request in writing.

Male health and ED clinic marketing: FDA device claims, ad rules and privacy